4583 — Chiome Bioscience Cashflow Statement
0.000.00%
Last trade - 00:00- ¥7bn
- ¥6bn
- ¥682m
Annual cashflow statement for Chiome Bioscience, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1,401 | -1,291 | -1,466 | -1,238 | -1,215 |
| Depreciation | |||||
| Non-Cash Items | — | — | 150 | — | — |
| Unusual Items | |||||
| Changes in Working Capital | -141 | -73.3 | 182 | 45.4 | 145 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -1,537 | -1,360 | -1,131 | -1,191 | -1,069 |
| Other Investing Cash Flow Items | -26.4 | -3.52 | -35.4 | — | 0.173 |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -26.4 | -3.52 | -35.4 | — | 0.173 |
| Financing Cash Flow Items | -4.36 | -5.94 | 14.6 | -0.001 | 5.79 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1,341 | 1,944 | 271 | 1,127 | 667 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -223 | 580 | -895 | -63.7 | -402 |